Changing the Future of Cancer Surgery...A 2017 Interview with Dr. Phil Low, Professor & Biotech Entrepreneur
About this episode
This episode features a 2017 interview with Dr. Phil Low discussing the impact of fluorescence-guided surgery on cancer treatment.
This week on BioTech Nation, we celebrate the life of the late Dr. Phil Low, Purdue University Distinguished Professor of Chemistry and biotech entrepreneur. In this 2017 interview, he describes the development of fluorescence-guided surgery - and why it's a game-changer for cancer treatment.
More episodes of BioTech Nation ... with Dr. Moira Gunn
- 50 Years of Genentech...Ashley Magargee, CEO, Genentech
- New treatment being tested for pre-term babies... Dr. Marc Salzberg, CEO and Chief Medical Officer, Airway Therapeutics
- Now, Near, Next...Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
- Who is Medically Qualified to Go to Space??? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
- Big Tech & Healthcare...Dr. Marschall Runge, Author, "The Great Healthcare Disruption"
- Regaining Function After Spinal Cord Injury: A New Path Forward? Dr. Adam Rogers, CEO, NervGen Pharma
Explore listener stats, chart rankings, contacts and more on the BioTech Nation ... with Dr. Moira Gunn podcast page.